scholarly article | Q13442814 |
P50 | author | Joshua A Goldberg | Q56501403 |
P2093 | author name string | D James Surmeier | |
Jayms D Peterson | |||
P2860 | cites work | LTP and LTD | Q22337342 |
A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation | Q24305050 | ||
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 | ||
A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD | Q28190142 | ||
Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications | Q28247343 | ||
Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function | Q28261240 | ||
Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number | Q28297899 | ||
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP | Q28377464 | ||
Structural basis of long-term potentiation in single dendritic spines | Q29547598 | ||
The functional anatomy of basal ganglia disorders | Q29617461 | ||
FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity | Q30491749 | ||
Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors | Q30495714 | ||
Thalamic gating of corticostriatal signaling by cholinergic interneurons. | Q30583147 | ||
The N-methyl-D-aspartate receptor antagonist CPP alters synapse and spine structure and impairs long-term potentiation and long-term depression induced morphological plasticity in dentate gyrus of the awake rat. | Q30955643 | ||
Differential excitability and modulation of striatal medium spiny neuron dendrites | Q33382961 | ||
Distribution, biochemistry and function of striatal adenosine A2A receptors | Q33740841 | ||
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
The thalamostriatal system: a highly specific network of the basal ganglia circuitry | Q34550491 | ||
Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. | Q34638023 | ||
A2A receptor and striatal cellular functions: regulation of gene expression, currents, and synaptic transmission | Q35603269 | ||
Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease | Q35793502 | ||
Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience | Q36172464 | ||
Adenosine-dopamine interactions revealed in knockout mice. | Q36191606 | ||
Modulation of striatal projection systems by dopamine | Q36367283 | ||
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism | Q36763909 | ||
Homeostatic signaling: the positive side of negative feedback | Q36798818 | ||
Re-emergence of striatal cholinergic interneurons in movement disorders | Q36955354 | ||
Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration | Q37323686 | ||
Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection | Q37629163 | ||
Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease | Q39732881 | ||
Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer | Q40599836 | ||
MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. | Q40817289 | ||
Locally dynamic synaptic learning rules in pyramidal neuron dendrites | Q42287800 | ||
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. | Q42493069 | ||
Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease | Q42497576 | ||
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
Corticostriatal and thalamostriatal synapses have distinctive properties | Q42551042 | ||
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug | Q43232822 | ||
Adenosine receptor expression and function in rat striatal cholinergic interneurons | Q43264704 | ||
G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. | Q45249950 | ||
D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. | Q45980594 | ||
Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons. | Q46644376 | ||
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. | Q46973834 | ||
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. | Q48226289 | ||
Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. | Q48391594 | ||
Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes | Q48433708 | ||
Warmer preparation of hippocampal slices prevents synapse proliferation that might obscure LTP-related structural plasticity | Q48452247 | ||
Downregulation of transient K+ channels in dendrites of hippocampal CA1 pyramidal neurons by activation of PKA and PKC. | Q48455965 | ||
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion | Q48540394 | ||
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease | Q60715991 | ||
Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo. | Q67401851 | ||
Muscarinic (m2/m4) receptors reduce N- and P-type Ca2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway | Q71483852 | ||
Adenosine receptor expression and modulation of Ca(2+) channels in rat striatal cholinergic interneurons | Q73352680 | ||
Probing fundamental aspects of synaptic transmission with strontium | Q73870623 | ||
P433 | issue | 1 | |
P921 | main subject | striatum | Q1319792 |
P304 | page(s) | 409-416 | |
P577 | publication date | 2011-09-10 | |
P1433 | published in | Neurobiology of Disease | Q15716606 |
P1476 | title | Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion | |
P478 | volume | 45 |
Q39502291 | A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. |
Q37048087 | Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses |
Q30650489 | Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia |
Q36889608 | Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency |
Q48309715 | Deconstructing behavioral neuropharmacology with cellular specificity |
Q92000933 | Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia |
Q35898412 | Endocannabinoid-dopamine interactions in striatal synaptic plasticity |
Q34362073 | Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse |
Q48541253 | Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits |
Q33692607 | Modulation of Ca2+-currents by sequential and simultaneous activation of adenosine A1 and A 2A receptors in striatal projection neurons. |
Q52370795 | Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases. |
Q38038559 | New synaptic and molecular targets for neuroprotection in Parkinson's disease |
Q36914301 | Npas1+ Pallidal Neurons Target Striatal Projection Neurons |
Q47843003 | On the role of adenosine (A)₂A receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats |
Q39157893 | Pathological overproduction: the bad side of adenosine. |
Q38142090 | The Enemy within: Propagation of Aberrant Corticostriatal Learning to Cortical Function in Parkinson's Disease |
Q33971113 | Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. |